trappin-2 A62L

derived from elafin and secretory leukocyte protease inhibitor; inhibits neutrophil serine protease

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Dallet-Choisy, Sandrine: 1 article (06/2012)
2.	Jourdan, Marie-Lise: 1 article (06/2012)
3.	Moreau, Thierry: 1 article (06/2012)
4.	Saidi, Ahlame: 1 article (06/2012)
5.	Tanga, Annabelle: 1 article (06/2012)
6.	Zani, Marie-Louise: 1 article (06/2012)

1.	Lung Diseases (Lung Disease) 06/15/2012 - "Thus, our data indicate that trappin-2 A62L is a powerful anti-protease and anti-inflammatory agent that could be used to develop a treatment for patients with inflammatory lung diseases."

1.	Peptide Hydrolases (Proteases)
2.	Anti-Inflammatory Agents (Anti-Inflammatories)